Fig. 4.
Evolution of CDR3 size profiles in patients 4 (DLI +20 months), 9 (DLI +17 months), 10 (DLI +15 months), and 18 (multiple DLI treatments between +23 and +36 months after BMT), all in whom GVHD developed, as indicated.
Patterns for 1 BV subfamily are shown for each patient at 6 time points after BMT.